[go: up one dir, main page]

AU2003300694A1 - Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them - Google Patents

Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them

Info

Publication number
AU2003300694A1
AU2003300694A1 AU2003300694A AU2003300694A AU2003300694A1 AU 2003300694 A1 AU2003300694 A1 AU 2003300694A1 AU 2003300694 A AU2003300694 A AU 2003300694A AU 2003300694 A AU2003300694 A AU 2003300694A AU 2003300694 A1 AU2003300694 A1 AU 2003300694A1
Authority
AU
Australia
Prior art keywords
moisture
basis
producing
pharmaceutical preparations
protected granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300694A
Inventor
Yatish Kumar Bansal
Veena Singh
Ramachandran Thembalath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipca Laboratories Ltd
Original Assignee
Ipca Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipca Laboratories Ltd filed Critical Ipca Laboratories Ltd
Publication of AU2003300694A1 publication Critical patent/AU2003300694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003300694A 2003-04-17 2003-10-31 Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them Abandoned AU2003300694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN384MU2003 2003-04-17
IN384/MUM/2003 2003-04-17
PCT/IN2003/000349 WO2004091582A1 (en) 2003-04-17 2003-10-31 Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them

Publications (1)

Publication Number Publication Date
AU2003300694A1 true AU2003300694A1 (en) 2004-11-04

Family

ID=33187221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300694A Abandoned AU2003300694A1 (en) 2003-04-17 2003-10-31 Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them

Country Status (2)

Country Link
AU (1) AU2003300694A1 (en)
WO (1) WO2004091582A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107716A1 (en) * 2004-03-25 2005-11-17 Cadila Healthcare Limited Controlled release paroxetine-containing tablets based on a core and a coating
WO2015038854A1 (en) * 2013-09-13 2015-03-19 R.P. Scherer Technologies, Llc Encased-pellet tablets

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152995A (en) * 1986-12-18 1992-10-06 Syntex (U.S.A.) Inc. Stable antibiotic ester feed compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
MX9306393A (en) * 1992-10-16 1994-04-29 Glaxo Group Ltd RANITIDINE COMPOSITIONS SUBSTANTIALLY FREE OF BITTER TASTE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
CA2315088A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
WO2004091582A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
AU2002351451A1 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
AU2003280324A1 (en) Pharmaceutical allergen product
AU2002344151A1 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003304243A1 (en) Process for the production of a fertilizer and fertilizer
EP1506014A4 (en) Process for the preparation and activation of substances and a means of producing same
AU2003262002A1 (en) Organopolysiloxane-modified polysaccharide and process for producing the same
AU2003207244A1 (en) Amino acid powder and process for producing the same
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2003252679A1 (en) Mechanoluminescence material and process for producing the same
AU2003260984A1 (en) S-(-)-amlodipine nicotinate and process for the preparation thereof
AU2003202566A1 (en) Granulated product and process to prepare the same
AU2003247023A1 (en) A process for the preparation of dispersible tablet of cephalexin
AU2003272911A1 (en) Granulation system and process for producing powder using granulation system
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003281698A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2003208084A1 (en) Phosmidosine derivative and process for producing the same
AU2003242338A1 (en) Medicine trial production supporting system
AU2003292581A1 (en) Latex particles and process for producing the same
AU2003300694A1 (en) Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
AU2003292820A1 (en) 4-amino-5-methylpyrazole derivatives and process for production thereof
AU2003286392A1 (en) 1microarrays and production thereof
AU2003264134A1 (en) Sarcolysyl derivatives and method for the production thereof
AU2003235121A1 (en) Novel thiol derivative, process for producing the same and use thereof
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase